Detalhe da pesquisa
1.
Enhanced and complementary benefits of a nalfurafine and fingolimod combination to treat immune-driven demyelination.
Clin Transl Immunology
; 12(12): e1480, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38090669